News for USA-based companies .

News for USA-based companies . http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 08 Feb 2012 03:47:37 +0100 Wed, 08 Feb 2012 03:47:37 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184 http://www.lifescience-online.com/Idenix_Announces_Removal_of_the_Partial_Clinical_H,30795.html?portalPage=Lifescience+Today.News

Area :: Anti-Infective
Category :: Scientific - Pipeline - Regulatory
Related companies :: IDENIX PHARMACEUTICALS INC
Related drugs :: IDX-184

]]> Thu, 02 Feb 2012 23:00:00 GMT News Merck and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302 http://www.lifescience-online.com/Merck_and_Threshold_Announce_Global_Agreement_to_C,30781.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Partnerships and Licensing
Related companies :: MERCK KGAA
THRESHOLD PHARMACEUTICALS INC
Related drugs :: TH-302

]]> Thu, 02 Feb 2012 23:00:00 GMT News Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results http://www.lifescience-online.com/Gilead_Sciences_Announces_Fourth_Quarter_and_Full_,30790.html?portalPage=Lifescience+Today.News

Category :: Finance and Income
Related companies :: GILEAD SCIENCES INC

]]> Wed, 01 Feb 2012 23:00:00 GMT News FDA Approves JANUMET(R) XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET(R) (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience http://www.lifescience-online.com/FDA_Approves_JANUMET__XR__sitagliptin_and_metformi,30784.html?portalPage=Lifescience+Today.News

Category :: Scientific - Pipeline - Regulatory
Related companies :: MERCK AND CO INC
Related drugs :: SITAGLIPTIN + METFORMIN

]]> Wed, 01 Feb 2012 23:00:00 GMT News Merck Announces Full-Year and Fourth-Quarter 2011 Financial Results http://www.lifescience-online.com/Merck_Announces_Full_Year_and_Fourth_Quarter_2011_,30786.html?portalPage=Lifescience+Today.News

Category :: Finance and Income
Related companies :: MERCK AND CO INC

]]> Wed, 01 Feb 2012 23:00:00 GMT News Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD) http://www.lifescience-online.com/Lubiprostone_Meets_Primary_Endpoint_in_Phase_3_Cli,30777.html?portalPage=Lifescience+Today.News

Area :: Gastrointestinal
Category :: Scientific - Pipeline - Regulatory
Related companies :: SUCAMPO PHARMACEUTICALS INC
Related drugs :: LUBIPROSTONE

]]> Wed, 01 Feb 2012 23:00:00 GMT News Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis Print http://www.lifescience-online.com/Agennix_AG_Halts_Phase_II_III_OASIS_Trial_in_Sever,30778.html?portalPage=Lifescience+Today.News

Area :: Immunomodulation
Category :: Scientific - Pipeline - Regulatory
Related companies :: AGENNIX AG
Related drugs :: TALACTOFERRIN

]]> Wed, 01 Feb 2012 23:00:00 GMT News Ligand Presents Full Data from Successful Phase II Trial of Captisol-Enabled(R), Propylene Glycol-Free Melphalan at the BMT Tandem Meetings http://www.lifescience-online.com/Ligand_Presents_Full_Data_from_Successful_Phase_II,30774.html?portalPage=Lifescience+Today.News

Area :: Immunomodulation
Category :: Scientific - Pipeline - Regulatory
Related companies :: LIGAND PHARMACEUTICALS INC
CYDEX PHARMACEUTICALS INC
Related drugs :: MELPHALAN

]]> Tue, 31 Jan 2012 23:00:00 GMT News